Intended for healthcare professionals
Our CompanySubscribeMy AccountLogin

Raising the bar for using surrogate endpoints in drug regulation and health technology assessment

scientist
scientist

Raising the bar for using surrogate endpoints in drug regulation and health technology assessment

Surrogate endpoints provide no guarantee of clinical benefit and should be used only as a last resort in drug trials, argue these authors

FeatureShould regulatory authorities approve drugs based on surrogate endpoints?OpinionSurrogate endpoints need complementary patient reported outcomes
A woman during a healthcare consultation
Menstrual changes after covid-19 vaccination

Changes to periods have been experienced shortly after covid-19 vaccination. We are still awaiting definitive evidence, says Victoria Male, but in the interim how should clinicians counsel patients?

editorial  |  Sep 16
Menstrual changes after covid-19 vaccination

Changes to periods have been experienced shortly after covid-19 vaccination. We are still awaiting definitive evidence, says Victoria Male, but in the interim how should clinicians counsel patients?

A woman during a healthcare consultation
editorial

Sep 16

Latest articles

News

Assisted dying

UK Jobs

Newbury Street Practice: Locum GP (6 months)

Current issue

latest issue
All articlesPast issues

Most read

1.

Community

Latest responses

View more

What are your thoughts?

Altmetrics

Altmetric Badge
Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study
Mar 9, 2021